| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37b59e8629e466e0c8f8cc4c72579491
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5351c62aee4203f2be2944f21a6def2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2017-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79fc45b349201ef8c42f47ef18d3192b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28ab31d15cc8dbafcc3745c927df0336
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12b4794632c27cfed60267d069a1a8e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f298c2a4d88227483ca401bdbafce008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93348a73001c7f59a7082b2598c40f95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1d6de2e330e8c3ba446ce2362bae2e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db289028465f734ce32888ebd9bec599 |
| publicationDate |
2019-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20190015827-A |
| titleOfInvention |
Method of providing the information for predicting adverse drug reaction |
| abstract |
The present invention relates to a method of providing information on the prediction of adverse drug reactions, and more particularly, to a method for providing information on the prediction of adverse drug reactions by examining a single base polymorphism of a fat mass and obesity-associated gene from a biological sample isolated from a patient, And to methods for predicting adverse reactions. The method of providing information on the prediction of drug harmful reaction according to the present invention can identify only a single nucleotide polymorphism and can significantly reduce the pain and / or the risk burden of the patient due to drug harmful reaction. Therefore, It is anticipated that it will be possible to prevent adverse drug reactions. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220160443-A |
| priorityDate |
2017-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |